Viralytics

Viralytics is an Australian oncolytic virus immunotherapy developer that focuses on the development and commercialization of oncolytic immunotherapies, which leverage the power of certain viruses to preferentially infect and kill cancer cells. Its core product is an intravenously deliverable oncolytic virus applicable for the treatment of diseases such as melanoma, prostate cancer, lung cancer, and bladder cancer.